» Articles » PMID: 35877198

The Clonal Relationship Between the Ductal and Lobular Components of Mixed Ductal-Lobular Carcinomas Suggested a Ductal Origin in Most Tumors

Abstract

The relationship between the ductal and lobular components of invasive ductolobular carcinomas (IDLC) has not been fully elucidated. In this study, the molecular alterations of both components were analyzed in a series of 20 IDLC that were selected, not only by morphologic criteria, but also by the loss of E-cadherin expression in the lobular component. We found that 80% of tumors shared alterations of driver genes in both components, being PIK3CA the most common alteration. In addition, 45% of IDLC carried CDH1 mutations in their lobular component that were absent in the ductal component. Fluorescent in situ hybridization analysis of the CDH1 gene excluded homozygous CDH1 loss as a frequent cause of E-cadherin loss in tumors without CDH1 mutations. In addition, no pathogenic mutations of catenin genes were detected in this series of tumors. In 25% of tumors, actionable mutations in PIK3CA , AKT1 , and ERBB2 were found in only 1 component. Altogether, our results confirm that most IDLC derive from invasive carcinoma of no special type, in which a population of cells lose E-cadherin and acquire a lobular phenotype. The frequency of CDH1 mutations in IDLC appears to be lower than in conventional invasive lobular carcinomas, suggesting the implication of alternative mechanisms of E-cadherin loss. Moreover, molecular heterogeneity between ductal and lobular areas suggests the need for molecular characterization of both components to guide targeted therapies.

Citing Articles

Comparison of Invasive Ductolobular Carcinoma and Lobular Carcinoma: An Observational Study.

Ucar M, Yilmaz M, Erdis E, Yucel B Medicina (Kaunas). 2025; 61(2).

PMID: 40005427 PMC: 11857455. DOI: 10.3390/medicina61020310.


Ipsilateral Breast Carcinoma Recurrence: True Recurrence or New Primary? A Clinicopathologic and Molecular Study.

Fernandez-Abad M, Caniego-Casas T, Carretero-Barrio I, Calderay-Dominguez M, Saavedra C, Hardisson D Am J Surg Pathol. 2025; 49(3):294-302.

PMID: 39780328 PMC: 11834960. DOI: 10.1097/PAS.0000000000002351.


Spatial molecular profiling of mixed invasive ductal and lobular breast cancers reveals heterogeneity in intrinsic molecular subtypes, oncogenic signatures, and mutations.

Shah O, Nasrazadani A, Foldi J, Atkinson J, Kleer C, McAuliffe P Proc Natl Acad Sci U S A. 2024; 121(31):e2322068121.

PMID: 39042692 PMC: 11295029. DOI: 10.1073/pnas.2322068121.


CDH1 methylation analysis in invasive lobular breast carcinomas with and without gene mutation.

Gonzalez-Martinez S, Kajabova V, Perez-Mies B, Carretero-Barrio I, Caniego-Casas T, Sarrio D Virchows Arch. 2024; 485(2):291-297.

PMID: 38713384 PMC: 11329400. DOI: 10.1007/s00428-024-03814-8.

References
1.
Sarrio D, Moreno-Bueno G, Hardisson D, Sanchez-Estevez C, Guo M, Herman J . Epigenetic and genetic alterations of APC and CDH1 genes in lobular breast cancer: relationships with abnormal E-cadherin and catenin expression and microsatellite instability. Int J Cancer. 2003; 106(2):208-15. DOI: 10.1002/ijc.11197. View

2.
Wolff A, Hammond M, Allison K, Harvey B, Mangu P, Bartlett J . Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update. Arch Pathol Lab Med. 2018; 142(11):1364-1382. DOI: 10.5858/arpa.2018-0902-SA. View

3.
McCart Reed A, Kalinowski L, Simpson P, Lakhani S . Invasive lobular carcinoma of the breast: the increasing importance of this special subtype. Breast Cancer Res. 2021; 23(1):6. PMC: 7792208. DOI: 10.1186/s13058-020-01384-6. View

4.
McCart Reed A, Foong S, Kutasovic J, Nones K, Waddell N, Lakhani S . The Genomic Landscape of Lobular Breast Cancer. Cancers (Basel). 2021; 13(8). PMC: 8073944. DOI: 10.3390/cancers13081950. View

5.
Cheang M, Chia S, Voduc D, Gao D, Leung S, Snider J . Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer. J Natl Cancer Inst. 2009; 101(10):736-50. PMC: 2684553. DOI: 10.1093/jnci/djp082. View